Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Koshy A. Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024. J Clin Exp Hepatol. 2025;15:102406. https://doi.org/10.1016/j.jceh.2024.102406.

Article  CAS  PubMed  Google Scholar 

De Stefano F, Chacon E, Turcios L, Marti F, Gedaly R. Novel biomarkers in hepatocellular carcinoma. Dig Liver Dis. 2018;50:1115–23. https://doi.org/10.1016/j.dld.2018.08.019.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45. https://doi.org/10.3322/caac.21871.

Article  PubMed  PubMed Central  Google Scholar 

Gray TA, Hernandez L, Carey AH, Schaldach MA, Smithwick MJ, Rus K, et al. The ancient source of a distinct gene family encoding proteins featuring RING and C(3)H zinc-finger motifs with abundant expression in developing brain and nervous system. Genomics. 2000;66:76–86. https://doi.org/10.1006/geno.2000.6199.

Article  CAS  PubMed  Google Scholar 

Borden KL. RING domains: master builders of molecular scaffolds? J Mol Biol. 2000;295:1103–12. https://doi.org/10.1006/jmbi.1999.3429.

Article  CAS  PubMed  Google Scholar 

Jia C, Tang H, Yang Y, Yuan S, Han T, Fang M, et al. Ubiquitination of IGF2BP3 by E3 ligase MKRN2 regulates the proliferation and migration of human neuroblastoma SHSY5Y cells. Biochem Biophys Res Commun. 2020;529:43–50. https://doi.org/10.1016/j.bbrc.2020.05.112.

Article  CAS  PubMed  Google Scholar 

Shin C, Ito Y, Ichikawa S, Tokunaga M, Sakata-Sogawa K, Tanaka T. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses. Sci Rep. 2017;7:46097. https://doi.org/10.1038/srep46097.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Application of Logistic Regression with Different Sampling Models. Applied Logistic Regression. John Wiley & Sons, Ltd. Hoboken

Wu L, Liu Y, Deng W, Wu T, Bu L, Chen L. OLR1 is a pan-cancer prognostic and immunotherapeutic predictor associated with EMT and cuproptosis in HNSCC. Int J Mol Sci. 2023;24:12904. https://doi.org/10.3390/ijms241612904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pathria G, Verma S, Yin J, Scott DA, Ronai ZA. MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction. EMBO Rep. 2021;22:e51436. https://doi.org/10.15252/embr.202051436.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. https://doi.org/10.1038/s41572-020-00240-3.

Article  PubMed  Google Scholar 

Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151–72. https://doi.org/10.1038/s41571-021-00573-2.

Article  CAS  PubMed  Google Scholar 

Jiang FZ, Xia QJ, Wu L, Zhang YM. Overexpression of MKRN2 inhibits the growth of ovarian cancer cells. Mol Biol (Mosk). 2023;57:687–8.

Article  CAS  PubMed  Google Scholar 

Qi P, Yexie Z, Xue C, Huang G, Zhao Z, Zhang X. LINC00294/miR-620/MKRN2 axis provides biomarkers and negatively regulates malignant progression in colorectal carcinoma. Hum Exp Toxicol. 2023;42:9603271231167577. https://doi.org/10.1177/09603271231167577.

Article  CAS  PubMed  Google Scholar 

Yang Y, Luo Y, Huang S, Tao Y, Li C, Wang C. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53. Cancer Biomark. 2023;36:267–78. https://doi.org/10.3233/CBM-210559.

Article  CAS  PubMed  Google Scholar 

Liu Z, Xiang S, Guo X, Zhou J, Liao L, Kou J, et al. MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2. Aging. 2022;14:2004–13. https://doi.org/10.18632/aging.203643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang J, Xu Y, Ren H, Wudu M, Wang Q, Song X, et al. MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway. J Exp Clin Cancer Res. 2018;37:189. https://doi.org/10.1186/s13046-018-0855-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Cui N, Zheng G. Ubiquitination of P53 by E3 ligase MKRN2 promotes melanoma cell proliferation. Oncol Lett. 2020;19:1975–84. https://doi.org/10.3892/ol.2020.11261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee KY, Chan KYY, Tsang KS, Chen YC, Kung H, Ng PC, et al. Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity. PLoS ONE. 2014;9:e92706. https://doi.org/10.1371/journal.pone.0092706.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu B, Zhang Y, Wang T, Guo J, Kong C, Chen Z, et al. MAPK signaling pathways in hepatic ischemia/reperfusion injury. J Inflamm Res. 2023;16:1405–18. https://doi.org/10.2147/JIR.S396604.

Article  PubMed  PubMed Central  Google Scholar 

Sugiura R, Satoh R, Takasaki T, ERK. A double-edged sword in cancer ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells. 2021. https://doi.org/10.3390/cells10102509.

Article  PubMed  PubMed Central  Google Scholar 

The Stress Kinase p38α as a Target for Cancer Therapy | Cancer Research | American Association for Cancer Research . https://aacrjournals.org/cancerres/article/75/19/3997/606389/The-Stress-Kinase-p38-as-a-Target-for-Cancer. Accessed 29 Sept 2025

Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG, et al. Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell. 2014;25:484–500. https://doi.org/10.1016/j.ccr.2014.02.019.

Article  CAS  PubMed  Google Scholar 

Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537–49. https://doi.org/10.1038/nrc2694.

Article  CAS  PubMed  Google Scholar 

Han J, Sun P. The pathways to tumor suppression via route p38. Trends Biochem Sci. 2007;32:364–71. https://doi.org/10.1016/j.tibs.2007.06.007.

Article  CAS  PubMed  Google Scholar 

Joseph S, Zhang X, Droby GN, Wu D, Bae-Jump V, Lyons S, et al. MAPK14/p38α shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics. Cell Rep. 2025;44:115104. https://doi.org/10.1016/j.celrep.2024.115104.

Article  CAS  PubMed  Google Scholar 

Witkiewicz AK, Kumarasamy V, Sanidas I, Knudsen ES. Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy. Trends Cancer. 2022;8:711–25. https://doi.org/10.1016/j.trecan.2022.04.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dang F, Nie L, Zhou J, Shimizu K, Chu C, Wu Z, et al. Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer. Nat Commun. 2021;12:5386. https://doi.org/10.1038/s41467-021-25700-6.

Article  CAS